Clinical Trials Logo

Primary Non-function clinical trials

View clinical trials related to Primary Non-function.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02798861 Completed - Liver Disease Clinical Trials

Controlled Attenuation Parameter (CAP) in Liver Allografts

Start date: September 7, 2016
Phase:
Study type: Observational

The primary aim is to determine the accuracy of CAP in the quantification of liver steatosis using liver biopsies as reference. Secondarily, investigators will correlate transient elastography (TE) and CAP results, analyze possible associations between CAP/TE and post-liver transplant (LT) clinical outcomes, and evaluate the change in CAP after LT. The study aims to include as many donors as needed to achieve at least 120 transplanted liver allografts.